Assessment of Nutritional Status and Role of Insulin-like Growth Factor-1 in Children
NCT ID: NCT05529550
Last Updated: 2022-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
102 participants
OBSERVATIONAL
2020-10-01
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus
NCT03851055
Endocrine and Nutritional Assessment in B Thalassemia Major
NCT00456690
Assessment of Cognitive Function, Fatigue and Health Related Quality of Life in Children With Beta Thalassemia
NCT05469230
Genetic Profile of Alpha Thalassemia Children at Sohag University Hospital .
NCT06591936
Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major
NCT02761395
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
67 children in the age group of 2-18 years with confirmed diagnosis of Beta thalassemia major.
No interventions assigned to this group
Healthy control
35 healthy children
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Children with malignancy
1 Year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Menoufia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samar Abdelhameed
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samar Abd El-Hameed
Shibīn al Kawm, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
insulin-like growth factor-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.